Effectiveness of ATMX in Treating Adolescents With ADHD and SUD

Clinical trial NCT00218322 · COMPLETED

Trial details

NCT number: NCT00218322
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity Substance-Related Disorders

Start date: 2004-09-01
Primary completion: 2006-03-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.